COVID-19 vaccine News
The most prevalent AESIs in adolescents included new-onset skin and subcutaneous disorders (10.5 per cent)
Serious AESI, which included stroke and Guillain-Barre syndrome, was reported in one per cent of individuals
Recently, AstraZeneca admitted in the UK High Court about a rare risk of blood clot disorder due to its Covid vaccine
The Nobel Assembly said the discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020.
Live | Coronavirus cases in India: The total case tally has been recorded at 4.47 crore and the daily positivity rate has been recorded at 4.39 per cent.
Addressing a gathering in Ramanagara as part of ‘Vijaya Sankalpa Yatre,’ Kateel took potshots at the Congress leaders for their initial resistance to the Covid-19 vaccines.
The study reveals despite the mismatch in variants, the booster remains protective against XBB.
According to Dr. Gangakhedkar, old people and those suffering from chronic morbidities should continue to take precautions such as wearing of masks.
During the Corona transition period, India was trying that foreign companies should also make vaccines in India so that the people of India could get the vaccine. Today in DNA, know why the Government of India did not buy the vaccine from abroad!
The DCGI's approval was based on recommendations by the subject expert committee (SEC) of the Central Drugs Standard Control Organisation.
The DCGI approved Covovax for restricted use in emergency situations in adults.
Covovax is manufactured through technology transfer from Novavax.
In the reply to an RTI filed by a Pune businessman, ICMR and CDSCO have admitted to multiple side effects of Covid-19 vaccination and the Covishield which was among the first vaccines approved by the Indian govt has the maximum number of side effects including paralysis of limbs of any particular side or parts of the body.
According to the South China Morning Post, as China eased its zero-Covid policy, the country doubled down on vaccination drives but the vaccination rate for the elderly is worryingly low. The vaccination figure fell to "just 42.4 per cent for those aged 80 and over", the report mentioned.
Blood cancer patients have weak immune systems and can fall grievously ill if they contract Covid-19
Vaccination can activate T cells, which are responsible for the long-term immune response
The study revealed that patients who can form antibodies tend to produce antibodies of particularly high quality
The nasal vaccine for coronavirus will be first available in the private hospitals.
"The government`s COVID vaccination program is in its final stages, but it`s still not over, approx 3 Cr Covid19 doses are still available with the government at the different centers and the stock is sufficient for a few months", officials said.
Another vaccine has been approved in the war against the corona epidemic. DCGI has approved Bharat Biotech's nasal vaccine for Corona. This will be the country's first nasal vaccine.
Corbevax will be available through the COWIN App in both public and private vaccination centres from Friday.
The price of the vaccine is Rs 400, including taxes and administrative charges.
The pharmaceutical company (BE) has, so far, delivered 10 crore doses of Corbevax to the Centre.
A vaccinator allegedly used a single vaccine to inoculate school students in Madhya Pradesh.
The vaccination officer has been suspended.
The incident took place on Wednesday in Sagar.
4 crore eligible beneficiaries are yet to take even a single Covid-19 vaccine shot
MoS Health Bharti Pravin said this in Lok Sabha
India crossed the 200 crore-vaccination mark on July 17 this year
Delhi CM urged people to get Covid booster dose.
He urged teens aged 12-17 to get their second dose of Covid-19 vaccine.
3.5 crore doses of Covid-19 vaccine has been administered in Delhi so far.
The study was conducted during the Delta and Omicron surges
Research found that high-risk patients who received NONS had a big reduction in viral load within 24 hours, which was sustained over 7 days of treatment
Viral load was reduced by 93.7 per cent within 24 hours and by 99 per cent within 48 hours of treatment with NONS.
Loading...
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
